(Press-News.org) A groundbreaking technology developed by Heriot-Watt University has received over £475,000 in funding to revolutionise how eczema is diagnosed and treated, potentially ending years of suffering for millions of patients across the UK.
The innovative vibroacoustic sensor, which measures material changes in each layer of skin using small vibrations on the surface, has received £275,000 from Scottish Enterprise and just over £200,000 from the Medical Research Council's Gap Fund to advance clinical testing. This research will support the development of a spin-out company based on the TissueMetrics project.
TissueMetrics’ solution addresses a critical gap in eczema and psoriasis treatment, where patients currently face a lengthy and frustrating cycle of trial and error with various creams and medications. Eczema, also called atopic dermatitis, affects up to 20% of children and 10% of adults in the UK, costing the NHS approximately £179 million annually in GP visits alone. Patients who suffer from this also end up spending on average over £500 per year on creams, soaps and moisturisers.
Ending the treatment lottery for millions
Existing eczema treatment pathways typically involve repeated visits to pharmacies and GPs, while the most severe cases are referred to hospital dermatology clinics. However, UK waiting times can stretch to 18 months, with some patients waiting years before finding effective treatments.
The research behind TissueMetrics’ sensor is being led by Professor Michael Crichton from Heriot-Watt University’s Global Research Institute in Health and Care Technologies.
Professor Crichton, who is based in the School of Engineering and Physical Sciences, said: "Our technology represents a fundamental shift in how we approach eczema management. Rather than relying solely on visual assessments, which haven't evolved in decades and can be particularly unreliable for patients with darker skin tones, our sensor provides objective measurements of what's happening beneath the skin's surface.”
Working on the technical engineering of the technology, Dr Connor Bain said: "By measuring the elasticity and viscoelasticity of each skin layer, we can detect changes in tissue stiffness and fluid content that indicate inflammation and disease progression. This allows healthcare professionals to make data-driven decisions about treatment effectiveness much earlier in the patient journey, potentially reducing the years of suffering many patients endure while trying to find the right treatment.
"What makes our approach particularly powerful is that it works equally well on all skin tones, avoiding the biases that can be common in visual assessments where parameters like redness are difficult to assess on darker skin. This could help address the well-documented healthcare disparities patients experience in dermatological care."
Bringing specialist care into community settings
The funding will help accelerate the progress of TissueMetrics, which aims to spin out in 2026 from Heriot-Watt University and supports the UK Government's plans to move more health treatments into community settings to relieve pressure on hospitals and GPs.
Dr Sara Medina-Lombardero, a research associate at Heriot-Watt University, is leading the patient and user clinical development of the technology. She commented: “The planned clinical evaluation will allow us to confidently correlate our objective measurements to those of specialist dermatologist assessments. Success will set us on a path where the sensor could enable treatment tracking and diagnoses to be made in local pharmacies and community healthcare facilities.”
Professor Richard Weller, dermatology lead for NHS Research Scotland and a University of Edinburgh academic based at the Institute for Regeneration and Repair, explained: "The current system for managing eczema is outdated and inefficient. Patients typically go through multiple cycles of treatment with increasingly potent and expensive medications, waiting weeks or months to see if each one works. Without objective measures, we're often making treatment decisions based on visual inspection alone, which can be very subjective.
"This technology has the potential to transform that process by providing quantitative data that can help us identify effective treatments much faster. It could enable high-quality dermatological care to be delivered in community settings, dramatically reducing waiting times and improving patient outcomes.
"For dermatologists, it would mean we could focus our specialist skills on the most complex cases, while still providing expert guidance to patients being treated in the community through the objective data their measurements provide."
Jane Martin Managing Director of Innovation and Investment at Scottish Enterprise said: “TissueMetrics’ technology could improve the health of millions of people with skin conditions like eczema. It is fantastic to see such ambition and growth as the company takes its products to market and spins out from Herriot-Watt University.
“We want to target future growth industries such as healthtech within life sciences to encourage more innovators and help Scottish companies to scale, ultimately benefitting the economy and in the case of TissueMetrics, improve lives too.”
The patient perspective
For eczema sufferers, the impact of the condition extends far beyond physical discomfort, affecting mental health, social interactions, and quality of life.
Asheema Kour, 24, has been living with severe eczema for several years. She explained: “I really want to go swimming and go to the gym but the risk of infection when I have a flare-up means I have to limit the activities I can do. The constant itching, the sleepless nights, and feeling self-conscious of visible flare-ups all have a psychological toll. But perhaps the most frustrating aspect is the wait for treatments to work. Additionally, every treatment has a physical impact on the body and essentially weakens the immune system. I don’t feel seen as a human being but more as a test subject where I am just told if I try another treatment then it will get better. The uncertainty is draining, and I’ve started to lose hope that I’ll ever find something effective.
“I definitely believe that being a South Asian woman is an added factor to the bias that I have faced from medical professionals where I feel diminished and my words undermined as my diagnosis doesn’t align with existing research. This is why I believe that not only representation within the profession is important but more diverse experiences should be embedded within medical research.
"A technology that could actually measure whether my treatment is working, rather than just waiting to see if symptoms improve, would be life changing. It would give people like me concrete evidence that we're on the right track much sooner in the process."
Clinical testing underway
The research team will now begin testing the sensor on patients with moderate eczema who are undergoing third or fourth-line treatments. They will also gather crucial feedback from patients and clinicians on its usability.
Professor Gillian Murray, deputy principal for business and enterprise at Heriot-Watt University said: "TissueMetrics’ innovation perfectly aligns with the UK Government's 10-year plan for the NHS with its emphasis on delivering more care in community settings. By enabling data-informed dermatological assessments to take place in local pharmacies and community facilities, we're helping to reduce pressure on overstretched hospitals whilst creating new market opportunities for groundbreaking technologies. It's a perfect example of how university research can drive economic growth through innovation that puts patients first and supports the future of healthcare delivery.
“This new funding will significantly accelerate the progression of TissueMetrics and help bring the sensor to patients more quickly, all while backed by the world-leading research and engineering capabilities we have here at Heriot-Watt University.”
Anyone interested in collaborating with the Global Research Institute in Health and Care Technologies can contact GRID@hw.ac.uk
END
Revolutionary skin sensing technology set to transform eczema and psoriasis treatment
Device could end years of trial-and-error treatment misery and long wait times for millions of sufferers
2025-10-02
ELSE PRESS RELEASES FROM THIS DATE:
Commercial sunbeds should be banned in the UK, say experts
2025-10-01
Commercial sunbeds should be banned in the UK, argue experts in The BMJ today.
Using sunbeds causes melanoma and other skin cancers, particularly among young people, yet existing sunbed legislation is ineffective and there is little evidence that stricter rules would help protect the most vulnerable, say Professor Paul Lorigan and colleagues.
Indoor tanning is experiencing a boom in popularity, particularly among Gen Z (born 1997-2012), with social media promoting sunbeds as integral to wellness, they explain. For example, a 2024 survey of 2,003 people in the UK by Melanoma Focus ...
Medical opposition to capital punishment is needed as executions surge
2025-10-01
The healthcare community has an important role in opposing the death penalty, argues an expert in The BMJ today.
Bharat Malkani, reader in law at Cardiff University, says doctors must refuse to participate in the execution process and speak out against a practice that is antithetical to their commitment to promote health and wellbeing.
Amnesty International reports that although the number of countries carrying out executions is decreasing, the number of executions in countries where it is legal has increased in recent years, he explains.
At least 1518 executions took place globally in 2024, rising from 1153 recorded in 2023, making it the fourth ...
India could bear biggest impact from chikungunya, new maps suggest
2025-10-01
The most comprehensive mapping to date of the global risk of chikungunya suggests India could experience the greatest long-term impact from the mosquito-borne virus.
Based on existing evidence of chikungunya transmission, the infectious disease model predicts 14.4 million people could be at risk of infections globally each year, with 5.1 million people at risk in India. It’s likely that chikungunya cases could also spread to regions not currently recording infections or considered at-risk, the analysis found, potentially increasing the number ...
Improved fertility diagnostics could boost bird conservation breeding programmes, say scientists
2025-10-01
A new analytical method is revealing how conservationists can further boost breeding programmes dedicated to saving some of the world’s most threatened species, according to new research led by the University of Sheffield and ZSL.
Conservation zoos, and the global breeding programmes they facilitate, are vital to maintaining or restoring populations and boosting genetic diversity of threatened birds. But not every egg produced in ...
Rice physicists’ new lab focused on emergent magnetic materials, funded by Department of Energy
2025-10-01
Four physicists from Rice University have received a $4.4 million grant over three years from the U.S. Department of Energy to establish the Rice Laboratory for Emergent Magnetic Materials (RLEMM). This new research center will investigate the fundamental interactions of magnetism and its role in next-generation technologies.
The award will support collaborative research led by principal investigator Pengcheng Dai along with co-investigators Ming Yi, Emilia Morosan and Qimiao Si. Their focus is on emergent phases of matter such as unconventional superconductivity, quantum ...
Oncotarget Editor-in-Chief Wafik S. El-Deiry chairs 2025 WIN Symposium in collaboration with APM in Philadelphia
2025-10-01
The WIN Symposium featured as the Oncology Track at the APM Annual Conference 2025 unites global leaders in oncology, translational science, and precision medicine.
BUFFALO, NY – October 1, 2025 – Oncotarget is proud to announce that its Editor-in-Chief, Wafik S. El-Deiry, MD, PhD, FACP, will chair the WIN Symposium as the Oncology Track of the Advancing Precision Medicine (APM) Annual Conference held October 3–4, 2025, at the Pennsylvania Convention Center in Philadelphia.
The WIN Consortium annual symposium featured as the Oncology ...
Can AI persuade you to go vegan—or harm yourself?
2025-10-01
Large language models are more persuasive than humans, according to recent UBC research.
Their vocabulary, perceived empathy and ability to provide tangible resources in seconds add to their persuasiveness, which has led to growing concerns and ongoing lawsuits about the potential for AI chatbots to cause harm to users.
In this Q&A, Dr. Vered Shwartz, UBC assistant professor of computer science and author of the book Lost in Automatic Translation, discusses her findings as well as potential safeguards for the future of AI.
Why does the persuasiveness of AI matter?
VS: Large ...
Outdoor air exposure to chemical may raise risk of Parkinson’s disease
2025-10-01
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, OCTOBER 1, 2025
Highlights:
Long-term exposure to a common industrial chemical may be linked to a higher risk of Parkinson’s disease.
Trichloroethylene (TCE) is a chemical used in metal degreasing and dry cleaning. Even though it has been banned for some uses, it remains in use today as an industrial solvent and lingers in air, soil and water across the U.S.
Researchers estimated long-term TCE exposure for more than 1.1 million older adults by using ZIP+4 codes and air pollution data.
Older adults living in areas with the highest TCE levels in outdoor air had a 10% higher ...
Why exercise could actually save your heartbeats - not waste them
2025-10-01
Forget the myth that exercise uses up your heartbeats. New Australian research shows fitter people use far fewer total heartbeats per day - potentially adding years to their lives.
Athletes had an average heart rate of 68 beats per minute (bpm), while non-athletes had 76bpm. That translates to a total of 97,920 beats per day for athletes and 109,440 beats per day for non-athletes – around 10 percent less.
“That’s an incredible saving of about 11,500 beats a day,” says Professor La Gerche, head of ...
Invasive mosquito vector species detected in surveillance traps in United Kingdom
2025-10-01
Aedes aegypti and Aedes albopictus mosquitoes are vectors of multiple diseases including dengue, chikungunya and Zika, posing a public health risk to populations within their native range. A study published in PLOS Global Public Health by Colin Johnston at Centre for Climate and Health Security, UK Health Security Agency, Porton Down, Salisbury, United Kingdom and colleagues describes the detection of invasive mosquito eggs in the United Kingdom in 2023 and 2024, suggesting an increasing incidence of importation of these species.
Historically, ...
LAST 30 PRESS RELEASES:
Knee-d for excellence: New regional training hub keeps surgeons sharp for ageing population
The Lancet: Billions lack access to healthy diets as food systems drive climate and health crises, but sustainable, equitable solutions are within reach, says new EAT-Lancet report
Countries with highest reported levels of hearing loss have lowest use of hearing aids
Early medical abortion at home up to 12 weeks is safe, effective, and comparable to hospital care
New approach to gravitational wave detection opens the Milli-Hz Frontier
Rice membrane extracts lithium from brines with greater speed, less waste
Exercise lowers disease risk. This researcher wants to understand how
Hurricane evacuation patterns differ based on where the storm hits
Stem Cell Reports welcomes new members to its Editorial Board
Researchers develop molecular qubits that communicate at telecom frequencies
Mayo Clinic awarded up to $40 million by ARPA-H for pioneering air safety research
People with Down syndrome have early neuroinflammation
CNIO researchers create the “human repairome”, a catalogue of DNA “scars” that will help define personalized cancer treatments
Strengthening biosecurity screening for genes that encode proteins of concern
Global wildfire disasters are growing in frequency and cost
Wildfire management: Reactive response and recovery, or proactive mitigation and prevention
Phosphine detected in the atmosphere of a low-temperature brown dwarf
Scientists develop rapid and scalable platform for in planta directed evolution
New tiny prehistoric fish species unlocks origins of catfish and carp
Plant microbiota: War and peace under the surface
Fossilized ear bones rewrite the history of freshwater fish
Detection of phosphine in a brown dwarf atmosphere raises more questions
USF study: Ancient plankton hint at steadier future for ocean life
MIT researchers find a simple formula could guide the design of faster-charging, longer-lasting batteries
Towards efficient room-temperature fluorine recovery from fluoropolymers
Mapping RNA-protein 'chats' could uncover new treatments for cancer and brain disease
The hidden burden of solitude: How social withdrawal influences the adolescent brain
Kidney disease study reveals unexpected marker
AI wrote nearly a quarter of corporate press releases in 2024
The ‘big bad wolf’ fears the human ‘super predator’ – for good reason
[Press-News.org] Revolutionary skin sensing technology set to transform eczema and psoriasis treatmentDevice could end years of trial-and-error treatment misery and long wait times for millions of sufferers